PET/CT scans for first staging of lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two types of scans to see how well they find cancer spread in people newly diagnosed with non-small cell lung cancer. It may help doctors choose the best scan for staging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer.
- You are 18 years or older.
- You have not started cancer treatment yet.
- Your blood sugar level is less than 200 mg/dl.
- You do not have another type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special PET scan can help predict if lung cancer has a certain gene change (EGFR) that might affect treatment options. It aims to see if the scan can be used instead of a biopsy to find this gene change.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This trial compares a new type of imaging scan (SPECT/CT) to the standard PET/CT scan to see if it can help diagnose and monitor lung cancer just as well. If you have lung cancer and are about to start treatment, you may be able to join to help test this new method.
This study uses a computer-generated PET scan from your CT scan to help doctors diagnose and plan treatment for non-small cell lung cancer more precisely. It is observational, meaning no new treatments are given—just extra imaging analysis.
This study uses a special PET/CT scan to better tell if a lung nodule is non-small cell lung cancer. If you have a solid nodule in your lung that's at least 8 mm and might be cancer, this scan could help get a clearer diagnosis.
This trial is testing whether adding a PET/CT scan to routine follow-up care helps patients with stage III non-small cell lung cancer. It aims to see if this extra imaging can detect any return of cancer earlier, which may help with treatment decisions.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.